SeraCare

In our latest Science Spotlight, we explore the paper "Analytical Validation of NeXT Personal, an Ultra-sensitive Personalized Circulating Tumor DNA Assay" published in Oncotarget In this paper, Personalis, Inc. describes NeXT Personal, an NGS-based assay for minimal residual disease (#MRD) monitoring of cancer recurrence following treatment. The team used the Seraseq?ctDNA MRD Panel Mix for whole genome sequencing of tumor and matched normal gDNAs to mimic determination of a patient-specific mutation profile, then sequenced dilutions of ctDNA to detect those mutations at very low concentrations. This established positive and negative predictive values at 100%, indicating robust analytical accuracy. Access Article Here: https://hubs.ly/Q02Z81Yv0 #CancerResearch #ctDNA #Oncology #Genomics

Exciting news from #AMP24! It’s been a busy few days filled with fantastic workshops and presentations, and we’re looking forward to more great conversations. Join us at booth 1427 at LGC Clinical Diagnostics—our team of experts is on-site, eager to share insights and have meaningful discussions. Don’t miss out—come by and say hello!

Don't Miss Out! Join the stream on Facebook LIVE in less than ONE HOUR as Paulo Pereira, Ph.D. discusses the importance of the use of a control in infectious serology tests for blood banks. Be sure to stick around as there will be a LIVE Q&A session following the presentation where we'll be giving away Paulo Pereira, Ph.D.'s “Quality Control of Qualitative Tests for Medical Laboratories” book to one lucky winner! #webinar #serology #qualitycontrols

Explore our educational resources on liquid biopsy methodologies and reference materials for NGS applications. Access 5 free posters that provide insights into measurable residual disease (MRD), tumor mutational burden (TMB), cfDNA extraction processes, and somatic mutation detection. Get insights into the practical applications of liquid biopsy for improving cancer management. Access Posters: https://hubs.ly/Q02YpSJg0 #LiquidBiopsy #CancerDiagnostics #NGS #MRD #TMB #cfDNA #SomaticMutations #CancerResearch #PrecisionMedicine #EducationalResources

Only a few days to go! Join us at #AMP2024, where our team of experts will share the latest insights in clinical genomics. Don't miss our workshop on improving liquid biopsy concordance using novel reference materials and be sure to check out our poster presentations on ctDNA, DPYD variants, and more. It’s the perfect chance to explore latest advancements in clinical assay validation. Learn more & schedule time with us – spots are limited! https://hubs.ly/Q02YfvKK0 See you in Vancouver! #AMP2024 #ClinicalGenomics #LiquidBiopsy #ReferenceMaterials #GenomicAssays #NGS #OncologyResearch #ClinicalDiagnostics #MolecularDiagnostics #GeneticTesting #ctDNA

In collaboration with Grupo LICON, join us for an exclusive webinar with special guest Paulo Pereira, Ph.D.! Join the stream on Facebook LIVE November 21st at 10 am EST as Paulo Pereira, Ph.D. discusses the importance of the use of a control in infectious serology tests for blood banks. Be sure to stick around as there will be a LIVE Q&A session following the presentation where we'll be giving away Paulo Pereira, Ph.D.'s “Quality Control of Qualitative Tests for Medical Laboratories” book to one lucky winner! #webinar #serology #qualitycontrols English Translation: "Low reactivity, big impact" Global Approach NOV 21 2024 9AM Mexico Time 10 AM EST Time Dr. Paulo Pereira Ph.D. With more than 15 years of experience as National Director of Quality. Recognize for his work in the performance of qualitative tests. Follow the transmission on: Facebook LIVE Importance of the use of a control in infectious serology tests for blood banks

Earn Continuing Professional Development (CPD) credits by participating in our webinar on Friday, November 22. Register now to attend: https://hubs.ly/Q02XZN1g0

It’s almost time! This Monday, we’ll be at MEDICA 2024 in Düsseldorf, running from November 11-14, at Booth #3C63. Our representatives are quickly filling their schedules, so don’t wait—book your meeting now! https://hubs.ly/Q02XyfRH0 #MEDICA2024

NEW PRODUCT! It's with the utmost excitement that we announce the launch of the ACCURUN? 350 CMV DNA Positive Control! This control is designed as a ready-to-use quality control solution to monitor day-to-day performance of CMV and transplant molecular assays. Order your kit today by clicking this link: https://hubs.ly/Q02XhkTf0 #molecularpcr #CMV

Looking for SeraCare or Seraseq? products at AMP? Join us from November 19-23 in Vancouver at Booth 1427! We’ll be showcasing our comprehensive suite of reference materials designed to enhance clinical genomics assays. Don’t miss our workshop on improving liquid biopsy concordance and explore our latest innovations! Our team is eager to discuss how our platform-agnostic solutions can support your development and validation needs. Let’s connect at the show: https://hubs.ly/Q02X6rKR0 #AMP2024 #SeraCare #Seraseq #ClinicalGenomics